HCA Healthcare Hits New 52-Week High of $443.28, Showcasing Strong Performance

HCA Healthcare, Inc. has reached a significant milestone by hitting a new 52-week high of USD 443.28 on October 22, 2025. This achievement underscores the company's strong performance in the hospital industry, particularly as it has recorded a remarkable 29.28% increase over the past year, significantly outperforming the S&P 500, which saw a gain of 15.06% during the same period.
With a market capitalization of USD 97,833 million, HCA Healthcare is classified as a large-cap company. The stock's price-to-earnings (P/E) ratio stands at 14.00, reflecting its valuation relative to earnings. Additionally, the company boasts a notable dividend yield of 76.73%, indicating a strong return for shareholders.

Despite the impressive stock performance, HCA Healthcare's financial metrics reveal a complex picture, with a return on equity of -156.67% and a price-to-book ratio of -22.27. The company's debt-to-equity ratio is reported at -9.89, suggesting a unique financial structure. Overall, HCA Healthcare's recent high marks a pivotal moment in its ongoing market journey.